Bleakley Financial Group »

Aquestive Therapeutics shares owned by Bleakley Financial Group

Quarter-by-quarter ownership of Aquestive Therapeutics (AQST) shares owned by Bleakley Financial Group from 13F filings

Historical chart of Bleakley Financial Group investment in Aquestive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aquestive Therapeutics held by Bleakley Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aquestive Therapeutics by Bleakley Financial Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $563k 136k 4.15

More positions owned by Bleakley Financial Group

Ishares Tr Core S&p500 Etf (IVV)
Sprott Asset Management Physical Gold An (CEF)
Apple (AAPL)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Index Fds Large Cap Etf (VV)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Mid Cap Etf (VO)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Vanguard Index Fds Value Etf (VTV)
Global X Fds 1-3 Month T-bill (CLIP)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Ishares Core Msci Emkt (IEMG)
Amazon (AMZN)

View all positions for Bleakley Financial Group

Top funds holding Aquestive Therapeutics

Bratton Capital Management
BlackRock
Rtw Investments
Vanguard Group
Federated Investors
Balyasny Asset Management
Samsara BioCapital
State Street Corporation
Geode Capital Management
Bank of America Corporation
Morgan Stanley
Susquehanna International
Two Sigma Investments
Jane Street
Janney Montgomery Scott

View all funds holding Aquestive Therapeutics